LI
ALT icon

LRI Investments’s Altimmune ALT Stock Holding History

LRI Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-123
Closed -$444 – 1417
2025
Q4 		$444 Buy
+123
New +$536 ﹤0.01% 1322

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

LRI Investments's ALT Position: Q1 2026 in Review

LRI Investments sold out of Altimmune (ALT) in Q1 2026, closing a stake of 123 shares — an estimated $444 sold.

LRI Investments first reported a position in ALT in Q4 2025 and held it in 1 quarter. The position peaked at $444 in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • LRI Investments reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • LRI Investments sold 123 Altimmune shares in Q1 2026, an estimated $444.
  • LRI Investments first reported a position in Altimmune in Q4 2025 and held it in 1 quarter.
  • LRI Investments's Altimmune position peaked at $444 in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on LRI Investments's 13F filing for Q1 2026, filed 30 Apr 2026.